EGFR and non-small cell lung carcinoma: Consistent with the anticancer activity found for indacaterol, canagliflozin and cis-flupenthixol in NSCLC cells, these drugs were also found to induce apoptosis in a concentration-dependent manner in the EGFR TKI-resistant H1975 cells (Figure 3).